Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT03654755

Public ClinicalTrials.gov record NCT03654755. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 10:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized open label study to evaluate the long term safety of ASN002 in subjects with moderate to severe atopic dermatitis (AD).

Study identification

NCT ID
NCT03654755
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Asana BioSciences
Industry
Enrollment
162 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 28, 2018
Primary completion
Oct 28, 2019
Completion
Oct 28, 2019
Last update posted
Sep 17, 2023

2018 – 2019

United States locations

U.S. sites
31
U.S. states
15
U.S. cities
28
Facility City State ZIP Site status
Pinnacle Research Group, LLC Anniston Alabama 36207
Total Skin and Dermatology Center, PC. Birmingham Alabama 35205
Center for Dermatology Clinical Research, Inc. Fremont California 94538
L.A. Universal Research Center, Inc. Los Angeles California 89148
Dermatology Research Associates Los Angeles California 90045
Revival Research Doral Florida 33122
Clinical Physiology Associates Fort Myers Florida 33912
Leavitt Medical Associates of Florida Ormond Beach Florida 32174
Dermatology Consulting Services Tampa Florida 33625
Forward Clinical Trials Tampa Florida 33625
Dawes Fretzin Clinical Research Group Indianapolis Indiana 46256
Dermatology Center of Indiana, PC Plainfield Indiana 46168
The Indiana Clinical Trials Center Plainfield Indiana 46168
Central Kentucky Research Associates, LLC Lexington Kentucky 40509
Dermatology Specialists Research Louisville Kentucky 40241
Tufts Medical Center Boston Massachusetts 02111
ActivMed Practices and Research, Inc. Portsmouth New Hampshire 03801
Corning Center for Clinical Research Corning New York 14830
Mt. Sinai Hospital New York New York 10029
Wake Research Associates, LLC Raleigh North Carolina 27612
Dermatologists of Greater Colombus Bexley Ohio 43209
Wright State Physicians Fairborn Ohio 45324
Unity Clinical Research Oklahoma City Oklahoma 73118
Vital Prospects Clinical Research Institute Tulsa Oklahoma 74136
DermDox Centers for Dermatology Hazleton Pennsylvania 18201
Synexus Greer South Carolina 29651
Dermatology Treatment and Research Center Dallas Texas 75320
Innovate Research, LLC Fort Worth Texas 76244
The Center for Skin Research Houston Texas 77056
Progressive Clinical Research San Antonio Texas 78213
Virginia Clinical Research, Inc. Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03654755, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 17, 2023 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03654755 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →